International audienceThe rapid and effective bone regeneration of large non-healing defects remains challenging. Bioactive proteins, such as bone morphogenetic protein (BMP)-2, are proved their osteoinductivity, but their clinical use is currently limited to collagen as biomaterial. Being able to deliver BMP-2 from any other biomaterial would broaden its clinical use. This work presents a novel means for repairing a critical size volumetric bone femoral defect in the rat by combining a osteoinductive surface coating (2D) to a polymeric scaffold (3D hollow tube) made of commercially-available PLGA. Using a polyelectrolyte film as BMP-2 carrier, we tune the amount of BMP-2 loaded in and released from the polyelectrolyte film coating over a l...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
Sustained and controlled delivery of growth factors, such as bone morphogenetic protein 2 (BMP-2), f...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
AbstractThe rapid and effective bone regeneration of large non-healing defects remains challenging. ...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
Sustained and controlled delivery of growth factors, such as bone morphogenetic protein 2 (BMP-2), f...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
Sustained and controlled delivery of growth factors, such as bone morphogenetic protein 2 (BMP-2), f...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
AbstractThe rapid and effective bone regeneration of large non-healing defects remains challenging. ...
International audienceThe rapid and effective bone regeneration of large non-healing defects remains...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
Sustained and controlled delivery of growth factors, such as bone morphogenetic protein 2 (BMP-2), f...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...
Sustained and controlled delivery of growth factors, such as bone morphogenetic protein 2 (BMP-2), f...
International audienceThe reconstruction of large bone defects (12 cm3) remains a challenge for clin...